EUDA Health (EUDA) files Form 6-K with H1 2025 interim results

Rhea-AI Filing Summary

EUDA Health Holdings Limited submitted a Form 6-K as a foreign private issuer to provide investors with its financial information for the six months ended June 30, 2025. The filing states that the company is furnishing unaudited condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024, along with unaudited condensed consolidated statements of operations and comprehensive loss for the comparable six-month periods in 2025 and 2024.

The submission also includes an operating and financial review and prospects section discussing these interim results. This interim package gives a mid-year view of EUDA Health Holdings Limited’s financial position, performance, and management’s commentary between its annual reports on Form 20-F.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-40678

EUDA Health Holdings Limited

(Exact Name of Registrant as Specified in its Charter)

60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: +65 6327 1110

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

EUDA Health Holdings Limited (the “Company”) is furnishing under the cover of Form 6-K its financial results for the six months ended June 30, 2025.

Exhibits

99.1	Unaudited Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024, and unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the Six Months Ended June 30, 2025 and 2024.
99.2	Operating and Financial Review and Prospects in connection with the Unaudited Interim Condensed Consolidated Financial Statements for the Six Months Ended June 30, 2025 and 2024

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: October 1, 2025
	EUDA Health Holdings Limited
	By:	/s/ Alfred Lim
	Name:	Alfred Lim
	Title:	Chief Executive Officer

3

FAQ

What did EUDA (EUDA) file in this Form 6-K?

EUDA Health Holdings Limited filed a Form 6-K as a foreign private issuer to furnish its financial results for the six months ended June 30, 2025, including unaudited interim financial statements and a related operating and financial review.

Which financial statements does EUDA (EUDA) provide with this Form 6-K?

The company provides unaudited condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024, and unaudited condensed consolidated statements of operations and comprehensive loss for the six months ended June 30, 2025 and 2024.

Does EUDA (EUDA) include management discussion with the interim results?

Yes. Alongside the unaudited interim condensed consolidated financial statements, EUDA Health Holdings Limited includes an Operating and Financial Review and Prospects section covering the six months ended June 30, 2025 and 2024.

Are EUDA’s interim financial statements in this Form 6-K audited?

The balance sheets and statements of operations and comprehensive loss furnished with this Form 6-K are described as unaudited condensed consolidated financial statements.

What reporting framework does EUDA (EUDA) use for annual reports?

The filing indicates that EUDA Health Holdings Limited files its annual reports under cover of Form 20-F, consistent with its status as a foreign private issuer.

Who signed EUDA’s Form 6-K for the June 30, 2025 interim results?

The Form 6-K was signed on behalf of EUDA Health Holdings Limited by Alfred Lim, who is identified as the company’s Chief Executive Officer.